These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3075903)

  • 1. Insulin treatment of non-insulin-dependent diabetes mellitus.
    Heine RJ
    Baillieres Clin Endocrinol Metab; 1988 May; 2(2):477-92. PubMed ID: 3075903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin treatment in elderly patients with non-insulin-dependent diabetes mellitus. A double-edged sword?
    Niskanen L
    Drugs Aging; 1996 Mar; 8(3):183-92. PubMed ID: 8720744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents.
    Krempf M; Godeau T; Ranganathan S; Blanchard P; Ritz P; Charbonnel B
    Eur J Clin Pharmacol; 1992; 42(3):281-6. PubMed ID: 1577046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M
    Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of sulphonylureas in the elderly.
    Graal MB; Wolffenbuttel BH
    Drugs Aging; 1999 Dec; 15(6):471-81. PubMed ID: 10641958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
    Wolffenbuttel BH; van Haeften TW
    Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring.
    Trovati M; Burzacca S; Mularoni E; Massucco P; Cavalot F; Mattiello L; Anfossi G
    Diabetologia; 1991 Sep; 34(9):662-7. PubMed ID: 1955099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of NIDDM with insulin agonists or substitutes.
    Galloway JA
    Diabetes Care; 1990 Dec; 13(12):1209-39. PubMed ID: 1980453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving glycaemic control with current therapies.
    Birkeland KI
    Diabet Med; 1998; 15 Suppl 4():S13-9. PubMed ID: 9868986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of diabetes in metabolic syndrome].
    Pelikánova T
    Vnitr Lek; 2009; 55(7-8):637-45. PubMed ID: 19731868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors.
    Lebovitz HE
    Drugs; 1992; 44 Suppl 3():21-8. PubMed ID: 1280574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin treatment in non-insulin dependent diabetes mellitus.
    Misra A
    Natl Med J India; 1995; 8(4):169-77. PubMed ID: 7633312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood glucose control and insulin secretion improved with combined therapy in type 2 diabetic patients with secondary failure to oral hypoglycaemic agents.
    Iavicoli M; Cucinotta D; De Mattia G; Lunetta M; Morsiani M; Pontiroli AE; Pozza G
    Diabet Med; 1988 Dec; 5(9):849-55. PubMed ID: 2976646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin-dependent diabetes.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Acta Clin Belg; 1993; 48(4):259-68. PubMed ID: 8212978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin therapy in type 2 diabetes: what is the evidence?
    van Avendonk MJ; Rutten GE
    Diabetes Obes Metab; 2009 May; 11(5):415-32. PubMed ID: 19175375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.